Skip to main content
Caplight Logo









Respirix, Inc.

Respirix, Inc.

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://respirix.com

Last Round

Early Funding

Aug 13, 2019

Total Funding Raised

$1.3M

Company Overview

Respirix, Inc. operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was an Early Funding round in August 2019.

Respirix, Inc. is a medical technology company that develops non-invasive hemodynamic monitoring hardware and software for the management of congestive heart failure.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Respirix, Inc. Comparables

Compare Respirix, Inc. with similar companies based on industry and business-model similarity.

Respirix, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bodyport
89%
Acorai
85%
AIKON Health
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Respirix, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingAug 13, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 13, 2019

    $1.3M raised in early funding.

Book a demo to see all signals

For institutional investors. Book with your work email.

Respirix, Inc. Filings

Explore SEC and related filing metadata, where available.

Respirix, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Respirix, Inc.'s valuation, stock price, and market status.

Is Respirix, Inc. a public or private company?

Respirix, Inc. is a private company.

What is the current stock price of Respirix, Inc.?

Respirix, Inc. is a private company, so its shares have no public market price. Caplight tracks Respirix, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Respirix, Inc. worth (valuation)?

Valuation information for Respirix, Inc. is not publicly available.

Can I buy Respirix, Inc. stock?

Respirix, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Respirix, Inc.'s last funding round?

Respirix, Inc.'s most recent funding round was Early Funding on August 13, 2019.

Who are the main investors in Respirix, Inc.?

Investor information for Respirix, Inc. is not publicly disclosed.

Will Respirix, Inc. IPO soon?

No public IPO plans have been announced for Respirix, Inc..

How can I track Respirix, Inc. secondary market activity?

Caplight tracks bids, offers, and trades in Respirix, Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersSan Francisco, California
Year Founded2015
Last FundingAug 13, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?